A need for consensus guideline update: recommend explicit restriction of methotrexate in end-stage renal patients

Rheumatology (Oxford). 2020 Nov 1;59(11):e93-e94. doi: 10.1093/rheumatology/keaa279.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy*
  • Consensus
  • Humans
  • Kidney Failure, Chronic / complications*
  • Male
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Practice Guidelines as Topic

Substances

  • Antirheumatic Agents
  • Methotrexate